Mode
Text Size
Log in / Sign up
N/A N=256 Randomized Treatment

Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19

Generalized Anxiety · Health Anxiety

Enrolled (actual)
256
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: GAD-7 — 4.7; 7.8; 4.9 score on a scale — p=0.071

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Anxiety Reduction Training (Behavioral); Kundalini Yoga and Anxiety Reduction Training (Behavioral); Meditation and Anxiety Reduction Training (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Research Foundation for Mental Hygiene, Inc.
Primary completion
Apr 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
GAD-7
4.7; 7.8; 4.9 0.071
PRIMARY
Whiteley 8
0.05; 3.9; 2.5 0.01 sig
SECONDARY
PHQ-8
4.8; 7.8; 4.5 0.08
SECONDARY
SS-8
-3.8; -2.8; -1.7 0.25
SECONDARY
Applied Cognition 1.0
-4.1; -6.6; -5.1 0.88
SECONDARY
PROMIS-4 Sleep Disturbance
1.5; 3.7; 3.3 0.038 sig
SECONDARY
ERQ
-1.9; -5.5; -2.9; -16.2; -13.9; -16.5 0.9
SECONDARY
Perceived Stress Scale
4.1; 6.0; 6.5 0.5
SECONDARY
Brief Hypervigilance Scale
1.2; 3.5; 0.4 0.076

Summary

This randomized clinical on-line study examines whether whether a daily practice of meditation or Kundalini Yoga with anxiety reduction training leads to a greater reduction in anxiety than anxiety reduction training alone.

Eligibility Criteria

Inclusion Criteria

  • Heightened anxiety triggered or exacerbated by COVID-19
  • Anxiety it least mild-moderate in severity
  • English speaking and living in the United States
  • Access to a smart phone, tablet, or computer with internet
  • Able to read and understand English

Exclusion Criteria

  • Individuals with severe depression or substance abuse
  • Individuals with a current or past history of psychosis, bipolar disorder, or PTSD.
  • Individuals with physical disability that might make study participation difficult.
  • Individuals with an unstable medical illness or a history of cardiac disease
  • Individuals with a current daily practice of meditation or Kundalini yoga
  • Individuals with confirmed or suspected COVID-19
  • Individuals who are currently pregnant or anticipate being pregnant during study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04386291). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search